A new trading day began on Tuesday, with Nuvation Bio Inc (NYSE: NUVB) stock price down -2.00% from the previous day of trading, before settling in for the closing price of $2.50. NUVB’s price has ranged from $1.52 to $4.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -504.76%. With a float of $229.10 million, this company’s outstanding shares have now reached $335.25 million.
In an organization with 51 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -32.69%, operating margin of -5541.88%, and the pretax margin is -21940.68%.
Nuvation Bio Inc (NUVB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Nuvation Bio Inc is 32.13%, while institutional ownership is 43.23%. The most recent insider transaction that took place on Nov 11 ’24, was worth 162,883. In this transaction CEO, ANHEART THERAPEUTICS LTD. of this company sold 56,361 shares at a rate of $2.89, taking the stock ownership to the 3,866,228 shares. Before that another transaction happened on Oct 08 ’24, when Company’s Director bought 100,000 for $2.20, making the entire transaction worth $220,000. This insider now owns 100,000 shares in total.
Nuvation Bio Inc (NUVB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -504.76% per share during the next fiscal year.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Here are Nuvation Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 382.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Let’s dig in a bit further. During the last 5-days, its volume was 3.11 million. That was inferior than the volume of 3.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.92%. Additionally, its Average True Range was 0.21.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 30.93%, which indicates a significant increase from 5.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.69% in the past 14 days, which was higher than the 74.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.73, while its 200-day Moving Average is $2.85. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $2.49. Second resistance stands at $2.53. The third major resistance level sits at $2.58. If the price goes on to break the first support level at $2.40, it is likely to go to the next support level at $2.35. The third support level lies at $2.31 if the price breaches the second support level.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
With a market capitalization of 827.04 million, the company has a total of 336,567K Shares Outstanding. Currently, annual sales are 0 K while annual income is -75,800 K. The company’s previous quarter sales were 730 K while its latest quarter income was -41,210 K.
